4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001179110-21-009815
SVP of Regulatory Affairs sold 600 shares at $41.71 ($25,026)
- SVP of Regulatory Affairs acquired 600 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heath-Chiozzi Margo SVP of Regulatory Affairs | 2021-11-01 | Option exercise | +600 | $2.78 | $1,668 | 11,847 | D |
| Heath-Chiozzi Margo SVP of Regulatory Affairs | 2021-11-01 | Sale | −600 | $41.71 | $25,026 | 11,247 | D |
| Derivatives | |||||||
| Heath-Chiozzi Margo SVP of Regulatory Affairs | 2021-11-01 | Option exercise · Incentive Stock Option (Right to Buy) | −600 | 42,400 | D | ||
| Open-market sales · 600 sh · avg $41.71 · $25,026 | |||||||
Loading xslF345X03/edgar.xml…